Wyndham Hotels & Resorts (WH) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
1 Dec, 2025Executive summary
Achieved record first-quarter global openings of 15,000 rooms, up 13% year-over-year, and a record development pipeline of 254,000 rooms, up 5% year-over-year.
System-wide rooms grew 4% year-over-year, with strong growth in higher RevPAR segments in the U.S. and EMEA/Latin America.
Net income rose to $61 million from $16 million in the prior-year quarter, reflecting improved operating performance and lower non-recurring expenses.
Awarded 181 new development contracts globally, a 6% increase year-over-year.
Returned $109 million to shareholders via $76 million in share repurchases and $33 million in dividends.
Financial highlights
Fee-related and other revenues increased 4% year-over-year to $316 million, driven by higher royalties and franchise fees.
Adjusted EBITDA grew 3% to $145 million, or 9% on a comparable basis excluding $8 million of marketing fund variability.
Diluted EPS was $0.78 versus $0.19 in the prior-year quarter; adjusted diluted EPS grew 10% to $0.86, or 20% on a comparable basis.
Free cash flow was $80 million, converting at 55% of adjusted EBITDA.
Net income for Q1 2025 was $61 million, up from $16 million in Q1 2024.
Outlook and guidance
Full-year 2025 outlook refined for softer-than-expected RevPAR; now expects global RevPAR growth of (2%) to (1%) and net room growth of 3.6% to 4.6%.
Adjusted EBITDA guidance lowered to $730–$745 million from $745–$755 million; adjusted diluted EPS now $4.57–$4.74.
Free cash flow conversion rate expected at ~57%.
Each 1% change in RevPAR impacts fee-related revenues by ~$10 million and adjusted EBITDA by ~$4 million.
Management expects sufficient liquidity to fund operations, growth, and shareholder returns.
Latest events from Wyndham Hotels & Resorts
- Strong 2025 results, robust governance, and ESG focus; board opposes written consent proposal.WH
Proxy filing25 Mar 2026 - Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Record room growth, resilient earnings, and strong capital returns despite RevPAR headwinds.WH
Q4 202519 Feb 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 202418 Jan 2026 - Record system growth, strong earnings, and new initiatives drive a positive 2025 outlook.WH
Q4 202429 Dec 2025 - Record growth, strong financials, and robust governance drive positive outlook for 2025.WH
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.WH
Proxy Filing1 Dec 2025 - System and pipeline growth offset RevPAR declines, driving higher earnings and strong cash returns.WH
Q3 202524 Oct 2025